RR

Raju Ramamoorthy

Active Director Director DIN 09017215
DIN 09017215 First appointment Jan 2021 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2021
Shareholding value •••• Premium profile

About Raju Ramamoorthy

Data last updated:

Raju Ramamoorthy is a Director at Beref Pharmaceuticals Private Limited (since 2021). The company operates in Pharma. Beref Pharmaceuticals Private Limited reported revenue of ₹14.86 Cr (FY 2025).

DIN 09017215
Primary Designation Director
Industry Pharma
First Appointment 02 Jan 2021
Oldest Company Age 5 yrs
Largest company Beref Pharmaceuticals Private Limited · ₹14.86 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director02 Jan 20212021₹14.86 Cr (FY 2025)Active

Board colleagues of Raju Ramamoorthy

Directorship timeline

Open interactive timeline →
Beref Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Raju Ramamoorthy

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Raju Ramamoorthy

Raju Ramamoorthy currently holds 1 directorship: Beref Pharmaceuticals Private Limited (Director, since 02 Jan 2021, revenue ₹14.86 Cr (FY 2025)).

Raju Ramamoorthy was first appointed on 02 Jan 2021 as Director at Beref Pharmaceuticals Private Limited.

The current boards of Raju Ramamoorthy's companies include Karuppiah Murugupandian (Beref Pharmaceuticals Private Limited), Vinayagam Senthil (Beref Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available